Aktis Oncology Inc (AKTS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Aktis Oncology Inc-Aktie (AKTS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	54.18% 9.027	5.855	7.51	7.017	7.002
Cost Of Revenue	27.20% 4.725	6.49	7.161	6.336	8.086
Gross Profit	777.48% 4.302	-0.635	0.349	0.681	-1.084
Operating Expenses	80.75% 9.638	50.07	22.96	15.71	20.57
Benefits Costs and Expenses	86.53% 15.45	114.66	30.82	22.73	27.13
Costs And Expenses	86.53% 15.45	114.66	30.82	22.73	1.883
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Depreciation and Amortization	63.42% 1.195	3.267	3.257	3.218	3.017
Operating Income/Loss	89.48% -5.336	-50.70	-22.61	-15.02	-21.65
Net Interest Income/Expense	4.81% -0.713	-0.749	-0.745	-0.679	-0.485
Nonoperating Income/Loss	98.14% -1.083	-58.10	-0.698	-0.685	1.526
Income/Loss From Continuing Operations Before Tax	94.10% -6.419	-108.80	-23.31	-15.71	-20.13
Income Tax Expense/Benefit	0.00% 0.001	0.001	0.002	0.002	0.001
Income/Loss From Continuing Operations After Tax	94.10% -6.42	-108.80	-23.31	-15.71	-20.13
Net Income/Loss	94.10% -6.42	-108.80	-23.31	-15.71	-20.13
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,408% 154.43	10.24	91.28	73.08	72.31
Diluted Average Shares	1,408% 154.43	10.24	91.28	73.08	72.31
Basic Earnings Per Share	96.49% -0.04	-1.14	-0.26	-0.21	-0.28
Diluted Earnings Per Share	96.49% -0.04	-1.14	-0.26	-0.21	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%